Malondong, Monrie C.

HRN: 08-37-44  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/11/2022
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
06/11/2022
06/18/2022
IV
500mg
Q8
T/C Acute Appendicitis
Waiting Final Action 

Indication:  ProphylaxisEmpiric    Type of Infection:  Intra-abdominal    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: